GR890100773A - Method for facing vascular diseases - Google Patents
Method for facing vascular diseasesInfo
- Publication number
- GR890100773A GR890100773A GR89100773A GR890100773A GR890100773A GR 890100773 A GR890100773 A GR 890100773A GR 89100773 A GR89100773 A GR 89100773A GR 890100773 A GR890100773 A GR 890100773A GR 890100773 A GR890100773 A GR 890100773A
- Authority
- GR
- Greece
- Prior art keywords
- facing
- vascular diseases
- vascular
- diseases
- facing vascular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27515188A | 1988-11-21 | 1988-11-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
GR890100773A true GR890100773A (en) | 1990-12-31 |
GR1001145B GR1001145B (en) | 1993-05-24 |
Family
ID=23051068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR890100773A GR1001145B (en) | 1988-11-21 | 1989-11-21 | Method for facing vascular diseases |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0444156A4 (en) |
CA (1) | CA2003382A1 (en) |
GR (1) | GR1001145B (en) |
WO (1) | WO1990005531A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE68045B1 (en) * | 1990-05-11 | 1996-05-15 | Abbott Lab | Renin inhibitors |
US5244910A (en) * | 1990-08-15 | 1993-09-14 | Abbott Laboratories | Renin inhibitors |
ZA921381B (en) * | 1991-03-01 | 1992-11-25 | Fujisawa Pharmaceutical Co | New use of amino acid derivatives |
SE9903028D0 (en) * | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
HUP0203326A3 (en) * | 1999-08-30 | 2003-04-28 | Sanofi Aventis Deutschland | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
EP1358178A2 (en) | 2001-01-30 | 2003-11-05 | Bristol-Myers Squibb Company | Sulfonamide lactam inhibitors of factor xa |
AU2017273857B2 (en) | 2016-06-01 | 2021-08-19 | Athira Pharma, Inc. | Compounds |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0161588A2 (en) * | 1984-05-18 | 1985-11-21 | MERCK PATENT GmbH | Diamino acid derivatives |
EP0179352A2 (en) * | 1984-10-20 | 1986-04-30 | MERCK PATENT GmbH | Peptides |
DE3626130A1 (en) * | 1986-08-01 | 1988-02-11 | Merck Patent Gmbh | AMINO ACID DERIVATIVES |
EP0272444A2 (en) * | 1986-11-27 | 1988-06-29 | MERCK PATENT GmbH | Renin-inhibiting peptides |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3538749A1 (en) * | 1985-10-31 | 1987-05-07 | Merck Patent Gmbh | PEPTIDE |
US7490044B2 (en) * | 2004-06-08 | 2009-02-10 | Bose Corporation | Audio signal processing |
-
1989
- 1989-11-20 CA CA002003382A patent/CA2003382A1/en not_active Abandoned
- 1989-11-20 WO PCT/US1989/005248 patent/WO1990005531A1/en not_active Application Discontinuation
- 1989-11-20 EP EP19900901238 patent/EP0444156A4/en not_active Withdrawn
- 1989-11-21 GR GR890100773A patent/GR1001145B/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0161588A2 (en) * | 1984-05-18 | 1985-11-21 | MERCK PATENT GmbH | Diamino acid derivatives |
EP0179352A2 (en) * | 1984-10-20 | 1986-04-30 | MERCK PATENT GmbH | Peptides |
DE3626130A1 (en) * | 1986-08-01 | 1988-02-11 | Merck Patent Gmbh | AMINO ACID DERIVATIVES |
EP0272444A2 (en) * | 1986-11-27 | 1988-06-29 | MERCK PATENT GmbH | Renin-inhibiting peptides |
Non-Patent Citations (2)
Title |
---|
CLAIM SEARCHED COMPLETELY: 5 * |
PARTIALLY SEARCHED CLAIMS: 1-4,6-9 * |
Also Published As
Publication number | Publication date |
---|---|
EP0444156A1 (en) | 1991-09-04 |
EP0444156A4 (en) | 1992-12-09 |
WO1990005531A1 (en) | 1990-05-31 |
CA2003382A1 (en) | 1990-05-21 |
GR1001145B (en) | 1993-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8814705D0 (en) | Method | |
ZA878399B (en) | Method for cryopreseving heart valves | |
GB8817240D0 (en) | Sterilising methods | |
GB8913090D0 (en) | Method | |
GB8822145D0 (en) | Method | |
GB8910302D0 (en) | Bonding method | |
GR890100773A (en) | Method for facing vascular diseases | |
GB8827847D0 (en) | Method | |
ZA907039B (en) | Method for activating protein c | |
BG50834A3 (en) | Method for the preparation of 3- acyl- 2- oxindole- 1- carboxamides | |
GB8829942D0 (en) | Method | |
GB9222141D0 (en) | Sanitary method | |
IL89593A (en) | Target association method | |
EP0327273A3 (en) | Dyeimage forming method | |
RO101205B1 (en) | Anilino-furamidine preparation method | |
PH25234A (en) | Expression method | |
GB8810354D0 (en) | Method | |
GB9200682D0 (en) | Noncorruptible read-writer method | |
GB8927300D0 (en) | Therapeutic method | |
GB8719038D0 (en) | Therapeutic method | |
GB8828501D0 (en) | New therapeutic method | |
GB8828500D0 (en) | New therapeutic method | |
GB8800738D0 (en) | New therapeutic method | |
KR0134034B1 (en) | Treatment method | |
BG47208A1 (en) | Method for tymphanostomy |